New Triple-Threat therapy tested for Tough-to-Treat lung cancer
NCT ID NCT04791839
Summary
This study is testing whether a combination of three investigational drugs is safe and effective for people with advanced non-small cell lung cancer whose disease has progressed after prior immunotherapy. The trial will enroll about 30 participants to see if the three drugs working together can shrink tumors and control the cancer. The goal is to find a new treatment option for patients who have run out of other approved therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.